InvestorsHub Logo

stoneroad

08/12/19 4:42 PM

#208238 RE: Mellowmood77 #208236

He’s a smarmy weaselly looking M’Fer. Karma’s a bitch.

sharinky

08/12/19 4:46 PM

#208240 RE: Mellowmood77 #208236

"I just hope he doesn’t have much sway with the ACC as he was acting President for a year, on the board of trustees for 10, and has served several terms on the Program Committee for the ACC Annual Scientific Sessions. "

Those are all was's. He does not hold those positions now. He is a has been because of his bias and the only people quoting him are Matthew Herper and Adam F.

zmanindc

08/12/19 5:03 PM

#208244 RE: Mellowmood77 #208236

Can you post the link to these quotes, I could use them as a reference for later emails.

Whalatane

08/12/19 5:24 PM

#208252 RE: Mellowmood77 #208236

Mellow. If Adcom panel was to ask Dr Nissen directly.

“ Based on the available data , do you think Vascepa should be approved for diabetics with prior events that fit the R-It parameters “

I’m betting that he would answer yes to that question . .... because probable benefit far outweighs probable risk ... in this high risk population .

What do you and others here think
Kiwi